U.S., Sept. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07189468) titled 'AI-based Progression and Medication Response Prediction Study in Parkinson's Disease' on Sept. 16.
Brief Summary: The study aims to provide initial PoC validation data of two AI models to predict disease progression and treatment side effects in PD patients using as input patients' demographic, clinical and genetic information, as well as digital biomarker measurements in daily living collected via a smartwatch and a mobile application.
Study Start Date: Oct. 06
Study Type: OBSERVATIONAL
Condition:
PARKINSON DISEASE (Disorder)
Intervention:
DEVICE: Smartwatch and mobile application
Wearing a smartwatch and using a mobile app...